The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin - PubMed (original) (raw)
The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin
Arne Forsgren et al. Infect Immun. 2003 Jun.
Abstract
The Moraxella catarrhalis immunoglobulin D (IgD)-binding protein (MID) is a 200-kDa outer membrane protein displaying a unique and specific affinity for human IgD. MID is found in the majority of M. catarrhalis strains. In the present paper, we show that MID-expressing M. catarrhalis strains agglutinate human erythrocytes and bind to type II alveolar epithelial cells. In contrast, M. catarrhalis isolates with low MID expression levels and two mutants deficient in MID, but with readily detectable UspA1 expression, do not agglutinate erythrocytes and have a 50% lower adhesive capacity. To examine the adhesive part of MID, the protein was dissected into nine fragments covering the entire molecule. The truncated MID proteins were expressed in Escherichia coli, purified, and used for raising polyclonal antibodies in rabbits. Interestingly, by using recombinant fragments, we show that the hemagglutinating and adhesive part of MID is localized within the 150-amino-acid fragment MID(764-913). In addition, antibodies against full-length MID, MID(764-913), or a 30-amino-acid consensus sequence (MID(775-804)) inhibited adhesion to alveolar epithelial cells. Antibodies against UspA1, an outer membrane protein expressed in essentially all M. catarrhalis strains, also inhibited adhesion, suggesting that both MID and UspA1 are needed for optimal attachment to epithelial cells. Taken together, in addition to MID-dependent IgD binding, we have demonstrated that the outer membrane protein MID is a novel adhesin that would be a suitable target for a future vaccine against M. catarrhalis.
Figures
FIG. 1.
Flow cytometry profiles of M. catarrhalis clinical isolates expressing MID at high or low intensity. IgD binding is shown for the high-intensity MID-expressing strain Bc5 (A and B) and the low-intensity MID-expressing strain BBH17 (C and D). MID expression intensity was defined according to the work of Möllenkvist et al. (22). Bacteria were incubated with human myeloma protein IgD(κ) followed by FITC-conjugated anti-IgD pAbs. Thereafter, fluorescence was analyzed by flow cytometry. Controls incubated with the FITC-conjugated anti-IgD pAb without preincubation with IgD are included (A and C).
FIG. 2.
High-intensity-MID-expressing M. catarrhalis isolates strongly adhere to epithelial cells, whereas low-intensity-MID-expressing strains and MID mutants do not. (A) Adhesion of six different M. catarrhalis strains with high or low expression of the outer membrane protein MID was studied. (B) Two different strains with mutated MID are compared to the corresponding wild-type strains. All clinical isolates expressed UspA1 as revealed by Western blotting. The M. catarrhalis strains were added to the type II alveolar epithelial cell line A549. After centrifugation, cells and bacteria were incubated for 30 min at 37°C, followed by extensive washes. Cells were treated with trypsin-EDTA, and suspensions were plated on blood agar plates and incubated overnight. CFU was counted, and attachment was calculated as a percentage of the inoculum, as follows: (CFU adherent)/(CFU added) × 100. Data are means from four independent experiments with duplicates. Error bars, standard errors of the means. The adhesion of the three high-intensity-MID-expressing strains was statistically different (P ≤ 0.01) from the adhesion of the three low-intensity-MID-expressing isolates.
FIG. 3.
MID binds to human erythrocytes, and the active domain is located between amino acid residues 764 and 913 (fragment E). (A) A series of truncated MID proteins (designated A to I) were manufactured and then used to immunize rabbits. The asterisk indicates the IgD-binding part of the MID molecule (23). (B) The resulting rabbit pAbs were equilibrated for antibody content as described in Materials and Methods. (C) The various truncated MID fragments were analyzed for binding to human erythrocytes by using the specific rabbit pAbs. Recombinant truncated proteins were produced in E. coli and purified by affinity chromatography as described in detail in Materials and Methods. On three occasions, rabbits were immunized with recombinant MID fragments. Microtiter plates were coated with a freshly isolated human erythrocyte membrane fraction, and the recombinant MID fragments were then added at the indicated concentrations (4.0, 0.5, or 0.125 μg/ml). Thereafter, specific rabbit anti-MID polyclonal antisera at dilutions equilibrated for specific antibody activity were added. After washes, plates were developed with HRP-conjugated goat anti-rabbit pAbs.
FIG. 4.
125I-labeled recombinant MID764-913 (fragment E) is specifically bound to erythrocytes and epithelial cells. 125I-labeled MID fragments (fragments A to I) were added to human erythrocytes (A) or to epithelial cells (B). All truncated MID proteins were produced in E. coli and purified by affinity chromatography. The resulting recombinant proteins were labeled with 125I and added to erythrocytes or the epithelial cell line A549. After several washes, bound radioactivity was measured in a γ-counter. Data are means from two experiments with duplicates. Error bars, standard deviations.
FIG. 5.
Adhesion of MID-expressing M. catarrhalis to epithelial cells depends on amino acid residues 764 to 913 (fragment E). Decreased adhesion to epithelial cells was observed with MID-expressing bacteria coated with a rabbit anti-MID1-2139, anti-MID764-913 (fragment E), anti-MID775-804, or anti-UspA1 pAb versus a preimmune serum or an anti-MID367-578 (fragment C) pAb. Bacteria were preincubated with the preimmune sera or specific antisera (dilution, 1/250), or with an anti-MID775-804 pAb (final concentration, 4.0 μg/ml), for 1 h at 4°C. Thereafter, bacteria were added to the epithelial cells, followed by centrifugation and incubation for 30 min at 37°C. After washes, cells were treated with trypsin-EDTA, and suspensions were plated onto blood agar plates. CFU were counted after an overnight incubation. The attachment ratio [(CFU adherent/CFU added) × 100] was calculated. All values were related to the adherence ratio obtained with the preimmune control serum (92% ± 4.3% [mean ± standard deviation] of the ratio for the control without any antisera), which was set to 100%. Data are means from four separate experiments with duplicates. Error bars, standard deviations. ***, P ≤ 0.001; **, P ≤ 0.01; *, P ≤ 0.05.
FIG. 6.
The MID molecule contains a coiled-coil structure within MID764-913 (fragment E). The full-length Bc5 MID1-2139 protein was analyzed by using Coils, version 2.2, software (19).
Similar articles
- The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.
Möllenkvist A, Nordström T, Halldén C, Christensen JJ, Forsgren A, Riesbeck K. Möllenkvist A, et al. J Bacteriol. 2003 Apr;185(7):2285-95. doi: 10.1128/JB.185.7.2285-2295.2003. J Bacteriol. 2003. PMID: 12644500 Free PMC article. - The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure.
Nordström T, Forsgren A, Riesbeck K. Nordström T, et al. J Biol Chem. 2002 Sep 20;277(38):34692-9. doi: 10.1074/jbc.M203858200. Epub 2002 Jul 10. J Biol Chem. 2002. PMID: 12110669 - Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.
Tan TT, Christensen JJ, Dziegiel MH, Forsgren A, Riesbeck K. Tan TT, et al. Infect Immun. 2006 Nov;74(11):6377-86. doi: 10.1128/IAI.00702-06. Epub 2006 Sep 11. Infect Immun. 2006. PMID: 16966403 Free PMC article. - MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
Riesbeck K, Tan TT, Forsgren A. Riesbeck K, et al. Acta Biochim Pol. 2006;53(3):445-56. Epub 2006 Sep 9. Acta Biochim Pol. 2006. PMID: 16964325 Review. - Structure and immunological action of the human pathogen Moraxella catarrhalis IgD-binding protein.
Riesbeck K, Nordstrom T. Riesbeck K, et al. Crit Rev Immunol. 2006;26(4):353-76. doi: 10.1615/critrevimmunol.v26.i4.40. Crit Rev Immunol. 2006. PMID: 17073558 Review.
Cited by
- Otitis media: recent advances in otitis media vaccine development and model systems.
Zahid A, Wilson JC, Grice ID, Peak IR. Zahid A, et al. Front Microbiol. 2024 Jan 24;15:1345027. doi: 10.3389/fmicb.2024.1345027. eCollection 2024. Front Microbiol. 2024. PMID: 38328427 Free PMC article. Review. - TLR2 regulates Moraxella catarrhalis adhesion to and invasion into alveolar epithelial cells and mediates inflammatory responses.
Ding R, Yu J, Ke W, Du L, Cheng G, Hu S, Xu Y, Liu Y. Ding R, et al. Virulence. 2024 Dec;15(1):2298548. doi: 10.1080/21505594.2023.2298548. Epub 2024 Jan 3. Virulence. 2024. PMID: 38169345 Free PMC article. - Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.
Murphy TF, Brauer AL, Pettigrew MM, LaFontaine ER, Tettelin H. Murphy TF, et al. J Infect Dis. 2019 Apr 16;219(9):1448-1455. doi: 10.1093/infdis/jiy680. J Infect Dis. 2019. PMID: 30496439 Free PMC article. - Vaccine targets against Moraxella catarrhalis.
Ren D, Pichichero ME. Ren D, et al. Expert Opin Ther Targets. 2016;20(1):19-33. doi: 10.1517/14728222.2015.1081686. Epub 2015 Aug 26. Expert Opin Ther Targets. 2016. PMID: 26565427 Free PMC article. Review. - A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.
Joslin SN, Pybus C, Labandeira-Rey M, Evans AS, Attia AS, Brautigam CA, Hansen EJ. Joslin SN, et al. Infect Immun. 2015 Jan;83(1):146-60. doi: 10.1128/IAI.02486-14. Epub 2014 Oct 13. Infect Immun. 2015. PMID: 25312959 Free PMC article.
References
- Bootsma, H. J., H. G. van der Heide, S. van de Pas, L. M. Schouls, and F. R. Mooi.2000. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J. Infect. Dis. 181:1376-1387. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources